| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.63B | 1.77B | 1.37B | 1.99B | 1.76B |
| Gross Profit | 535.88M | 615.68M | 386.70M | 604.17M | 494.32M |
| EBITDA | 136.29M | 199.71M | -2.57M | 244.45M | 184.43M |
| Net Income | 97.60M | 112.47M | -37.12M | 139.44M | 144.49M |
Balance Sheet | |||||
| Total Assets | 1.84B | 1.99B | 1.80B | 1.86B | 2.06B |
| Cash, Cash Equivalents and Short-Term Investments | 398.69M | 328.76M | 296.34M | 486.73M | 703.02M |
| Total Debt | 295.02M | 309.48M | 336.02M | 351.54M | 456.88M |
| Total Liabilities | 825.97M | 955.60M | 835.76M | 916.40M | 1.26B |
| Stockholders Equity | 1.02B | 1.04B | 960.73M | 946.19M | 797.02M |
Cash Flow | |||||
| Free Cash Flow | 154.25M | 93.95M | -261.95M | -49.15M | 77.02M |
| Operating Cash Flow | 227.91M | 167.68M | -173.64M | 23.08M | 158.14M |
| Investing Cash Flow | 4.31M | -70.42M | -57.94M | -116.50M | -58.87M |
| Financing Cash Flow | -182.26M | -60.81M | 61.08M | -104.12M | 399.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$16.86B | 22.79 | 13.39% | 3.23% | 8.72% | 12.71% | |
73 Outperform | HK$30.34B | 7.96 | 14.66% | 3.32% | 9.96% | 7.15% | |
70 Outperform | HK$10.16B | 14.44 | 11.01% | 1.57% | 0.33% | -23.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$945.84M | 8.09 | 4.79% | 7.16% | -5.00% | -24.22% | |
60 Neutral | HK$8.27B | 10.86 | 9.65% | 8.66% | -8.30% | -13.14% | |
45 Neutral | HK$2.21B | 9.23 | -69.18% | ― | -10.60% | ― |